Clinical trials
ARDS (Moderate or Severe) clinical trials
Below are recruiting ards (moderate or severe) clinical trials, each written for real people, not researchers. We’re tracking 1,471 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07694648Recruiting
Watching for germs that cause breathing problems
This study tracks patients with breathing problems to see which germs are making them sick. Doctors will use tests and medical records to watch for different pathogens.
Beijing, Beijing MunicipalityAges Any age - NCT07692217Recruiting
Joint health study for severe hemophilia A patients on new therapies
This study checks joint health and bleeding risk in people with severe hemophilia A who are taking newer factor VIII treatments or emicizumab. It uses ultrasound and blood tests to see how well these therapies protect joints.
Dallas, TexasAges 6 months+ - NCT06655389Recruiting
Link between PLA levels and sepsis heart failure severity
This study looks at how levels of a substance called PLA relate to how severe sepsis-related heart failure is. It may help doctors understand your condition better and guide treatment.
Beijing, Beijing MunicipalityAges 50–90 - NCT07682766Recruiting
Biomarkers of inflammation and infection in critical care
This study looks at markers of inflammation, infection, and immunity in patients who are in the critical care area. It aims to find early signs of how severe the illness might become, how well treatments work, and if infections will develop.
TorinoAges 18 years+ - NCT07684508Recruiting
Shorter radiation therapy after surgery for cervical cancer
This trial tests a shorter course of radiation therapy (fewer sessions) after hysterectomy for cervical cancer. It aims to see if it's safe and effective for patients who meet certain criteria based on their tumor type and recovery.
Beijing, Beijing MunicipalityAges 18–75 - NCT07674290RecruitingPhase 4
Study of MC4R Agonist for Bardet-Biedl Syndrome and Genetic Obesity
This trial tests a drug called setmelanotide for people with Bardet-Biedl Syndrome (a rare genetic condition) or other severe genetic obesity. It looks at how well the drug works in real-world settings, not just in a lab.
EssenAges Any age - NCT07673250Enrolling by invitation
Personalized breathing settings for ECMO patients
This study tests whether personalized breathing machine settings can improve outcomes for people on ECMO (a heart-lung support machine). It is designed for patients who have had or are waiting for a lung or heart transplant.
La Jolla, CaliforniaAges 18 years+ - NCT06670248Recruiting
Study of blood vessel health during burn surgery
This trial looks at how a protective layer inside your blood vessels (called the glycocalyx) responds during surgery to remove burned skin. The goal is to improve care for people with major burns.
Barcelona, SpainAges 18 years+ - NCT07665268RecruitingPhase 4
Comparing wound healing products for hard-to-heal pressure ulcers
This trial tests if special wound dressings (called cellular, acellular, or matrix-like products) can help heal severe pressure ulcers that haven't improved with standard care. It may be a good option if you have a stage 3 or 4 pressure ulcer on your lower back or tailbone area that's been there for at least a month.
North Royalton, OhioAges 18 years+ - NCT07669805Recruiting
Mindfulness and lifestyle program for older adults
This study tests a program that combines mindfulness practices and lifestyle changes to improve well-being in adults aged 55 and older. It may help reduce loneliness and support mental health.
Hualien City, TaiwanAges 55 years+ - NCT07664358Recruiting
Predicting lung injury after traumatic brain injury
This study looks at whether a simple blood test measuring fibrinogen and albumin levels can help predict if someone with a traumatic brain injury will develop a serious lung condition called acute respiratory distress syndrome (ARDS). It may help doctors identify patients who need extra monitoring and care.
Tanta, Gharbia GovernorateAges 18 years+ - NCT07666438Recruiting
Lung infections in children with chronic lung disease of prematurity
This study looks at children born very early who have chronic lung disease (BPD) and get a lung infection. Doctors want to learn more about how these infections affect breathing and health over time.
Bologna, BolognaAges 4 weeks–7 years - NCT07665658Recruiting
Supplements for ADHD: Calming brain inflammation in kids
This study tests whether special supplements can help calm inflammation in the brain and improve ADHD symptoms in children. It might be a good fit if your child's ADHD is diagnosed and they are not taking antibiotics or have other health issues like gut problems or severe allergies.
Peshawar, KPKAges 6–12 - NCT07667504Recruiting
Dietary approaches for weight management in type 1 diabetes
This study tests two different diet approaches to help people with type 1 diabetes who are overweight or obese manage their weight. It aims to find out which eating plan works better for blood sugar control and weight loss.
Málaga, MálagaAges 18–65 - NCT07665762RecruitingPhase 3
Numbing medicine for arm surgery pain prevention
This trial compares two additives to standard numbing medicine given before wrist fracture surgery to see which better prevents severe pain. You may qualify if you have risk factors for hard-to-control pain after surgery.
Hong KongAges 18–90 - NCT07666360Recruiting
Jaw pain study: factors that predict TMD severity
This trial looks at how your head, neck, and jaw work together to understand why some people have more severe jaw joint (TMD) pain. If you have jaw pain, the findings may help researchers identify better treatments.
AnkaraAges 18–55 - NCT04763447RecruitingPhase 4
Short omalizumab treatment for severe allergic asthma
This trial tests whether stopping omalizumab for a short time (or using it differently) can be safe for adults with severe allergic asthma who are doing well. It may help some people avoid long-term injections, but only if asthma remains well controlled.
Paris, Île-de-France RegionAges 18 years+ - NCT07663331RecruitingPhase 4
Adalimumab for adults with non-infectious uveitis
This study tests an injection called adalimumab (Tebiovio®) to see if it helps control inflammation in the eyes of adults with non-infectious uveitis. It might be a good option if you are already on steroid pills and looking for another treatment.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06678594Recruiting
A standardized method for treating hardened heart artery blockages
This trial is testing a new step-by-step approach (algorithm) to treat hardened, calcified blockages in heart arteries during a stent procedure. The goal is to see if this standardized method helps improve outcomes for patients with these tough-to-treat blockages.
DublinAges 18 years+ - NCT07658547Enrolling by invitation
AI Chatbots for Mental Health
This trial tests if an AI chatbot can help people with a diagnosed mental illness. It aims to find a new way to support your mental health.
Rüdersdorf, BrandenburgAges 18 years+ - NCT06668649Recruiting
Polish fatigue scale study for MS, ALS, or stroke
This study tests a Polish version of a scale that measures how tired people feel. It's for people with MS, ALS, or stroke, or healthy volunteers.
Krakow, Lesser Poland VoivodeshipAges 18 years+ - NCT06680895Recruiting
FeNO study in ICU patients with breathing support
This study measures a lung inflammation marker called FeNO in ICU patients on a breathing machine. It may help doctors understand lung health and guide treatment.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07654855Recruiting
Long-term safety of eplontersen in ATTR patients
This study follows people who already took part in an earlier trial (D8450R00003) to see how safe eplontersen is over the long term. It also includes people who had a liver transplant or severe liver problems.
Los Angeles, CaliforniaAges 18 years+ - NCT07652970Recruiting
Home video therapy for severe stroke recovery
This study tests whether a new therapy done at home via video calls can help people with severe, long-lasting stroke regain leg movement and walking ability. If you have trouble walking or moving your leg on one side, this may be an option.
Chicago, IllinoisAges 18–80
Hear when a new ARDS (Moderate or Severe) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ards (moderate or severe)?
- Yes. Clin2 currently lists 1,471 recruiting ards (moderate or severe) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ards (moderate or severe) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ards (moderate or severe) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.